Patient death raises safety concerns before Bristol Myers lung drug readout

A patient died from a fatal liver injury while taking part in a trial of Bristol Myers Squibb's lung disease candidate.

The company disclosed the incident in a May amendment to its trial documents, noting it as a single case of fatal liver injury.

The death has sparked safety questions as the trial approaches its upcoming data readout, prompting analysts and regulators to scrutinize the candidate's risk profile.